Back to Journals » Therapeutics and Clinical Risk Management » Volume 8

Review

Interest in paromomycin for the treatment of visceral leishmaniasis (kala-azar)

         
Total article views   Abstract views HTML views PDF downloads Totals
11,122 Dovepress* 7,014 605+ 2,084 7,619
PubMed Central* 0 3,503 463 3,503
Totals 7,014 4,108 2,547 11,122
*Since 22 June 2012
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed Central and Google Scholar